Asset Management
Compare Stocks
2 / 10Stock Comparison
BENF vs GAIN
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
BENF vs GAIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Asset Management | Asset Management |
| Market Cap | $1.86B | $657M |
| Revenue (TTM) | $-8M | $90M |
| Net Income (TTM) | $-50M | $130M |
| Gross Margin | 312.1% | 68.6% |
| Operating Margin | 304.4% | 72.7% |
| Forward P/E | 54.6x | 40.7x |
| Total Debt | $118M | $456M |
| Cash & Equiv. | $1M | $14M |
BENF vs GAIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 21 | May 26 | Return |
|---|---|---|---|
| Beneficient (BENF) | 100 | 0.4 | -99.6% |
| Gladstone Investmen… (GAIN) | 100 | 96.7 | -3.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BENF vs GAIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BENF is the clearest fit if your priority is growth exposure.
- Rev growth 92.0%, EPS growth 100.0%
- 92.0% NII/revenue growth vs GAIN's -12.9%
- +10.1% vs GAIN's +30.8%
GAIN carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 0.53, yield 10.0%
- 319.3% 10Y total return vs BENF's -99.6%
- Lower volatility, beta 0.53, Low D/E 91.3%, current ratio 3.69x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 92.0% NII/revenue growth vs GAIN's -12.9% | |
| Value | Lower P/E (40.7x vs 54.6x) | |
| Quality / Margins | 72.7% margin vs BENF's -6.4% | |
| Stability / Safety | Beta 0.53 vs BENF's 0.69, lower leverage | |
| Dividends | 10.0% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | +10.1% vs GAIN's +30.8% | |
| Efficiency (ROA) | 10.5% ROA vs BENF's -14.7%, ROIC 5.3% vs -10.0% |
BENF vs GAIN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
BENF leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
GAIN and BENF operate at a comparable scale, with $90M and -$8M in trailing revenue. GAIN is the more profitable business, keeping 72.7% of every revenue dollar as net income compared to BENF's -6.4%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | -$8M | $90M |
| EBITDAEarnings before interest/tax | -$85M | $58M |
| Net IncomeAfter-tax profit | -$50M | $130M |
| Free Cash FlowCash after capex | -$44M | -$82M |
| Gross MarginGross profit ÷ Revenue | +3.1% | +68.6% |
| Operating MarginEBIT ÷ Revenue | +3.0% | +72.7% |
| Net MarginNet income ÷ Revenue | -6.4% | +72.7% |
| FCF MarginFCF ÷ Revenue | +4.9% | +126.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +103.0% | +58.1% |
Valuation Metrics
GAIN leads this category, winning 2 of 2 comparable metrics.
Valuation Metrics
At 9.3x trailing earnings, GAIN trades at a 83% valuation discount to BENF's 54.6x P/E.
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.9B | $657M |
| Enterprise ValueMkt cap + debt − cash | $2.0B | $1.1B |
| Trailing P/EPrice ÷ TTM EPS | 54.57x | 9.28x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 40.66x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 16.82x |
| Price / SalesMarket cap ÷ Revenue | — | 7.31x |
| Price / BookPrice ÷ Book value/share | 33.48x | 1.22x |
| Price / FCFMarket cap ÷ FCF | — | 5.77x |
Profitability & Efficiency
GAIN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
BENF delivers a 89.3% return on equity — every $100 of shareholder capital generates $89 in annual profit, vs $22 for GAIN. GAIN carries lower financial leverage with a 0.91x debt-to-equity ratio, signaling a more conservative balance sheet compared to BENF's 2.12x. On the Piotroski fundamental quality scale (0–9), BENF scores 6/9 vs GAIN's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +89.3% | +21.9% |
| ROA (TTM)Return on assets | -14.7% | +10.5% |
| ROICReturn on invested capital | -10.0% | +5.3% |
| ROCEReturn on capital employed | -13.1% | +6.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 |
| Debt / EquityFinancial leverage | 2.12x | 0.91x |
| Net DebtTotal debt minus cash | $117M | $441M |
| Cash & Equiv.Liquid assets | $1M | $14M |
| Total DebtShort + long-term debt | $118M | $456M |
| Interest CoverageEBIT ÷ Interest expense | -4.75x | 1.58x |
Total Returns (Dividends Reinvested)
GAIN leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GAIN five years ago would be worth $17,205 today (with dividends reinvested), compared to $45 for BENF. Over the past 12 months, BENF leads with a +1010.4% total return vs GAIN's +30.8%. The 3-year compound annual growth rate (CAGR) favors GAIN at 16.1% vs BENF's -83.9% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -51.6% | +20.7% |
| 1-Year ReturnPast 12 months | +1010.4% | +30.8% |
| 3-Year ReturnCumulative with dividends | -99.6% | +56.5% |
| 5-Year ReturnCumulative with dividends | -99.6% | +72.0% |
| 10-Year ReturnCumulative with dividends | -99.6% | +319.3% |
| CAGR (3Y)Annualised 3-year return | -83.9% | +16.1% |
Risk & Volatility
GAIN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
GAIN is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than BENF's 0.69 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GAIN currently trades 96.3% from its 52-week high vs BENF's 35.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.69x | 0.53x |
| 52-Week HighHighest price in past year | $9.96 | $17.14 |
| 52-Week LowLowest price in past year | $0.26 | $13.11 |
| % of 52W HighCurrent price vs 52-week peak | +35.3% | +96.3% |
| RSI (14)Momentum oscillator 0–100 | 49.4 | 69.9 |
| Avg Volume (50D)Average daily shares traded | 295K | 371K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
GAIN is the only dividend payer here at 10.05% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $15.00 |
| # AnalystsCovering analysts | — | 7 |
| Dividend YieldAnnual dividend ÷ price | — | +10.0% |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | $1.66 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
GAIN leads in 4 of 6 categories (Valuation Metrics, Profitability & Efficiency). BENF leads in 1 (Income & Cash Flow).
BENF vs GAIN: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is BENF or GAIN a better buy right now?
For growth investors, Beneficient (BENF) is the stronger pick with 92.
0% revenue growth year-over-year, versus -12. 9% for Gladstone Investment Corporation (GAIN). Gladstone Investment Corporation (GAIN) offers the better valuation at 9. 3x trailing P/E (40. 7x forward), making it the more compelling value choice. Analysts rate Gladstone Investment Corporation (GAIN) a "Hold" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BENF or GAIN?
On trailing P/E, Gladstone Investment Corporation (GAIN) is the cheapest at 9.
3x versus Beneficient at 54. 6x.
03Which is the better long-term investment — BENF or GAIN?
Over the past 5 years, Gladstone Investment Corporation (GAIN) delivered a total return of +72.
0%, compared to -99. 6% for Beneficient (BENF). Over 10 years, the gap is even starker: GAIN returned +319. 3% versus BENF's -99. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BENF or GAIN?
By beta (market sensitivity over 5 years), Gladstone Investment Corporation (GAIN) is the lower-risk stock at 0.
53β versus Beneficient's 0. 69β — meaning BENF is approximately 30% more volatile than GAIN relative to the S&P 500. On balance sheet safety, Gladstone Investment Corporation (GAIN) carries a lower debt/equity ratio of 91% versus 2% for Beneficient — giving it more financial flexibility in a downturn.
05Which is growing faster — BENF or GAIN?
By revenue growth (latest reported year), Beneficient (BENF) is pulling ahead at 92.
0% versus -12. 9% for Gladstone Investment Corporation (GAIN). On earnings-per-share growth, the picture is similar: Beneficient grew EPS 100. 0% year-over-year, compared to -27. 9% for Gladstone Investment Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BENF or GAIN?
Gladstone Investment Corporation (GAIN) is the more profitable company, earning 72.
7% net margin versus -644. 0% for Beneficient — meaning it keeps 72. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BENF leads at 304. 4% versus 72. 7% for GAIN. At the gross margin level — before operating expenses — BENF leads at 312. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — BENF or GAIN?
In this comparison, GAIN (10.
0% yield) pays a dividend. BENF does not pay a meaningful dividend and should not be held primarily for income.
08Is BENF or GAIN better for a retirement portfolio?
For long-horizon retirement investors, Gladstone Investment Corporation (GAIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
53), 10. 0% yield, +319. 3% 10Y return). Both have compounded well over 10 years (GAIN: +319. 3%, BENF: -99. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between BENF and GAIN?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BENF is a small-cap high-growth stock; GAIN is a small-cap deep-value stock. GAIN pays a dividend while BENF does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.